Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Murakami, Masanori"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Calcium Polycarbophil in the Management of Fecal Incontinence.
    (2016) Abe, Tatsuya; Kunimoto, Masao; Hachiro, Yoshikazu; Ebisawa, Yoshiaki; Hishiyama, Houhei; Murakami, Masanori
    Background: Few clinical studies have assessed the efficacy of calcium polycarbophil that is currently recommended as an ideal and initial bulk-forming agent in patients with fecal incontinence. Aims: The aim of this study was to evaluate the short-term outcomes of calcium polycarbophil administration to patients with fecal incontinence due to a range of etiologies. Study Design: This was a retrospective review of a single-institution experience. Methodology: In total, 223 patients treated with calcium polycarbophil were enrolled. Efficacy measures included changes in the Cleveland Clinic Incontinence Score and the Bristol Stool Form Scale. Results: Of the 223 patients who were enrolled, 195 were available for final analysis. Among the 195 patients, 15 (7.7%) experienced side effects; the most common side effects were constipation and hard stools. One month after the start of treatment, the mean Cleveland Clinic Incontinence Score decreased significantly compared with baseline (11.2±4.0 vs. 5.7±5.0, P = < .001). The mean stool consistency decreased significantly, with patients reporting more formed stools by the Bristol Stool Form Scale at 1 month than at baseline (4.4±1.5 vs. 3.9±1.1, P = < .001). Conclusions: Our findings suggest that monotherapy with calcium polycarbophil appears to be a safe and beneficial approach in the management of fecal incontinence.

IMSEAR is the collaborative product of Health Literature, Library and Information Services (HELLIS) Network Member Libraries in the WHO South-East Asia Region.
HELLIS is coordinated by WHO Regional Office for South-East Asia.

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback